메뉴 건너뛰기





Volumn 20, Issue 5, 2009, Pages 321-333

Acquired vorinostat resistance shows partial cross-resistance to 'second-generation' HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities.

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENZAMIDE DERIVATIVE; DEPSIPEPTIDE; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HYDROXAMIC ACID; JNJ 26481585; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1; N (2 AMINOPHENYL) 4 ((4 PYRIDIN 3 YLPYRIMIDIN 2 YLAMINO)METHYL)BENZAMIDE; N-(2-AMINOPHENYL)-4-((4-PYRIDIN-3-YLPYRIMIDIN-2-YLAMINO)METHYL)BENZAMIDE; PANOBINOSTAT; PYRIMIDINE DERIVATIVE; ROMIDEPSIN; TUMOR PROTEIN; VORINOSTAT;

EID: 67650296574     PISSN: None     EISSN: 14735741     Source Type: Journal    
DOI: 10.1097/cad.0b013e3283262a32     Document Type: Article
Times cited : (41)

References (0)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.